Press Release Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune Royalty Pharma plc · Jul 22
Press Release Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy Radiopharm Theranostics · Jul 22
Press Release SOLV Energy to Report Second Quarter 2026 Financial Results on August 13, 2026 SOLV Energy, Inc. · Jul 22
Press Release Danantara Opens Lenders Panel for Indonesia Waste-to-Energy Financing Danantara Indonesia · Jul 22
Press Release Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline Mentari Therapeutics · Jul 22
Press Release Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference Castle Biosciences, Inc. · Jul 22
Press Release Coleman® and Kane Brown Celebrate Multi-Year Partnership with the Launch of Limited-Edition Collection Newell Brands · Jul 22
Press Release NEW TIAA INSTITUTE SURVEY FINDS THREE IN FOUR OF TODAY’S RETIREES WISH THEY HAD SAVED EARLIER AND SAVED MORE TIAA Institute · Jul 22
Press Release VinFast: As Electric Vehicles Become More Common, What Makes a Better Transportation System VinFast · Jul 22